Mostrar el registro sencillo del ítem
Effect of miR-21 in mesenchymal stem cells-derived extracellular vesicles behavior
dc.contributor.author | Morente López, Miriam | * |
dc.contributor.author | Mato Basalo, Rocío | * |
dc.contributor.author | Lucio-Gallego, S. | * |
dc.contributor.author | Gil, C. | * |
dc.contributor.author | Carrera, M. | * |
dc.contributor.author | Fafian Labora, Juan | * |
dc.contributor.author | Mateos Martín, Jesús | * |
dc.contributor.author | Arufe Gonda, Mª del Carmen | * |
dc.date.accessioned | 2025-09-09T10:23:28Z | |
dc.date.available | 2025-09-09T10:23:28Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Morente-López M, Mato-Basalo R, Lucio-Gallego S, Gil C, Carrera M, Fafián-Labora JA, et al. Effect of miR-21 in mesenchymal stem cells-derived extracellular vesicles behavior. Stem Cell Research and Therapy. 2023;14(1). | |
dc.identifier.issn | 1757-6512 | |
dc.identifier.other | https://portalcientifico.sergas.gal//documentos/65911de9ae63c86e421ba13a | |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/21393 | |
dc.description.abstract | Background: A challenging new branch of research related to aging-associated diseases is the identification of miRNAs capable of modulating the senescence-associated secretory phenotype (SASP) which characterizes senescent cells and contributes to driving inflammation. Methods: Mesenchymal stem cells (MSC) from human umbilical cord stroma were stable modified using lentivirus transduction to inhibit miR-21-5p and shotgun proteomic analysis was performed in the MSC-derived extracellular vesicles (EV) to check the effect of miR-21 inhibition in their protein cargo. Besides, we studied the paracrine effect of those modified extracellular vesicles and also their effect on SASP. Results: Syndecan-1 (SDC1) was the most decreased protein in MSC-miR21?-derived EV, and it was involved in inflammation and EV production. MSC-miR21?-derived EV were found to produce a statistically significant inhibitory effect on SASP and inflammaging markers expression in receptor cells, and in the opposite way, these receptor cells increased their SASP and inflammaging expression statistically significantly when treated with MSC-miR-21+-derived EV. Conclusion: This work demonstrates the importance of miR-21 in inflammaging and its role in SASP through SDC1. Graphical abstract: [Figure not available: see fulltext.] | |
dc.description.sponsorship | J.A.F-L was funded by Xunta de Galicia, Grants Number (ED481D-2021-020, 11_IN858A_2021_114114 and ED431F 2023/030), the Ministerio de Ciencia e Innovacion (RYC2021-032567-I) and the InTalent program from UDC-Inditex for the research grant. J.M. acknowledge the support of Xunta de Galicia (GAIN) by Talent Senior research grant (11_IN858A_2021_1141142). M.C.A. has been funded by Instituto de Salud Carlos III through the project PI20/00497. Co-funded by European Regional Development Fund A way to make Europe. Subsidy granted by the Carlos III Proteomics Network Platform, ProteoRed, within the ProteoRed Proof of Concept Projects program. The funding body played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. | |
dc.language | eng | |
dc.rights | Attribution 4.0 International (CC BY 4.0) | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.mesh | Humans | * |
dc.subject.mesh | Proteomics | * |
dc.subject.mesh | MicroRNAs | * |
dc.subject.mesh | Inflammation | * |
dc.subject.mesh | Extracellular Vesicles | * |
dc.subject.mesh | Mesenchymal Stem Cells | * |
dc.title | Effect of miR-21 in mesenchymal stem cells-derived extracellular vesicles behavior | |
dc.type | Artigo | |
dc.authorsophos | Morente-López, M.; Mato-Basalo, R.; Lucio-Gallego, S.; Gil, C.; Carrera, M.; Fafián-Labora, J.A.; Mateos, J.; Arufe, M.C. | |
dc.identifier.doi | 10.1186/s13287-023-03613-z | |
dc.identifier.sophos | 65911de9ae63c86e421ba13a | |
dc.issue.number | 1 | |
dc.journal.title | Stem Cell Research and Therapy | * |
dc.organization | Servizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Biomédica de A Coruña (INIBIC) | |
dc.organization | Instituto de Investigación Biomédica de A Coruña (INIBIC) | |
dc.organization | Servizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Unidade de investigación | |
dc.organization | Servizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Lugo::Oncoloxía médica | |
dc.organization | Servizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Biomédica de A Coruña (INIBIC)::Fisioterapia | |
dc.relation.projectID | Xunta de Galicia [ED481D-2021-020, 11_IN858A_2021_114114, ED431F 2023/030] | |
dc.relation.projectID | Ministerio de Ciencia e Innovacion [RYC2021-032567-I] | |
dc.relation.projectID | InTalent program from UDC-Inditex | |
dc.relation.projectID | Xunta de Galicia (GAIN) by Talent Senior research grant [11_IN858A_2021_1141142] | |
dc.relation.projectID | Instituto de Salud Carlos III [PI20/00497] | |
dc.relation.projectID | European Regional Development Fund A way to make Europe | |
dc.relation.projectID | Carlos III Proteomics Network Platform, ProteoRed, within the ProteoRed Proof of Concept Projects program | |
dc.relation.publisherversion | https://doi.org/10.1186/s13287-023-03613-z | |
dc.rights.accessRights | openAccess | * |
dc.subject.keyword | AS A Coruña | |
dc.subject.keyword | INIBIC | |
dc.subject.keyword | INIBIC | |
dc.subject.keyword | AS A Coruña | |
dc.subject.keyword | CHUAC | |
dc.subject.keyword | AS Lugo | |
dc.subject.keyword | CHULA | |
dc.subject.keyword | AS A Coruña | |
dc.subject.keyword | INIBIC | |
dc.typefides | Artículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis) | |
dc.typesophos | Artículo Original | |
dc.volume.number | 14 |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International (CC BY 4.0)
